Dr. Mary-Elizabeth Percival
Claim this profileFred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Area of expertise
Acute Myeloid Leukemia
Mary-Elizabeth Percival has run 3 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Intestinal Maturation
Mary-Elizabeth Percival has run 2 trials for Intestinal Maturation. Some of their research focus areas include:
Affiliated Hospitals
Fred Hutchinson Cancer Research Center/University Of Washington Cancer Consortium
Fred Hutch/University Of Washington Cancer Consortium
Clinical Trials Mary-Elizabeth Percival is currently running
More about Mary-Elizabeth Percival
Clinical Trial Related
7 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Mary-Elizabeth Percival has experience with
- Gemtuzumab Ozogamicin
- FLAG-Ida
- Pivekimab Sunirine
- 5-azacitidine
- APG-115
Breakdown of trials Mary-Elizabeth Percival has run
Acute Myeloid Leukemia
Intestinal Maturation
Myelodysplastic Syndrome
Monocytic Leukemia
Myelodysplastic/Myeloproliferative Neoplasm
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mary-Elizabeth Percival specialize in?
Mary-Elizabeth Percival focuses on Acute Myeloid Leukemia and Intestinal Maturation. In particular, much of their work with Acute Myeloid Leukemia has involved CD33 positive patients, or patients who are Stage I.
Is Mary-Elizabeth Percival currently recruiting for clinical trials?
Yes, Mary-Elizabeth Percival is currently recruiting for 1 clinical trial in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Mary-Elizabeth Percival has studied deeply?
Yes, Mary-Elizabeth Percival has studied treatments such as Gemtuzumab Ozogamicin, FLAG-Ida, Pivekimab Sunirine.
What is the best way to schedule an appointment with Mary-Elizabeth Percival?
Apply for one of the trials that Mary-Elizabeth Percival is conducting.
What is the office address of Mary-Elizabeth Percival?
The office of Mary-Elizabeth Percival is located at: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington 98109 United States. This is the address for their practice at the Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.